Discriminative stimulus effects of the NMDA receptor antagonists MK-801 and CGP 37849 in rats

Pharmacology Biochemistry and Behavior

Volumn 55, Issue 1, 1996, Pages 163-168

  Zajaczkowski, Wojciech ^a   Moryl, Elzbieta ^a   Papp, Mariusz ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Amphetamine; CGP 37849; Cocaine; Drug discrimination; Fenfluramine; Memantine; MK 801; Rats

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; AMPHETAMINE; COCAINE; DIZOCILPINE; FENFLURAMINE; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG MECHANISM; INSTRUMENTAL CONDITIONING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; STIMULUS GENERALIZATION;

ANIMALIA;

EID: 0030248698     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02290-2     Document Type: Article

References (54)

1. 1. Balster, R. L. The behavioral pharmacology of phencyclidine. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:1573.
2. 2. Bennett, D. A.; Bernard, C. L.; Amrick, D. E.; Wilson, J. M.; Liebman, J. M.; Hutchinson, A. J. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 250:454-460; 1989.
3. 3. Bobelis, D. J.; Balster, R. L. Pharmacological specificity of the discriminative stimulus properties of 2-amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid (NPC 12626), a competitive N-methyl-D-aspartate receptor antagonists. J. Pharmacol. Exp. Ther. 264: 845-853; 1993.
4. 4. Bormann, J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol. 166:591-592; 1989.
5. 5. Bubser, M.; Keseberg, U.; Notz, P. K.; Schmidt, W. J. Different behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur. J. Pharmacol. 229:75-82; 1992.
6. 6. Butelman, E. R.; France, C. P.; Woods, J. H. The discriminative stimulus effects of MK-801 in pigeons. Behav. Pharmacol. 2: 79-86; 1991.
7. 2 mediation of the discriminative stimulus properties d-amphetamine and cocaine. Psychopharmacology (Berlin) 103: 50-55; 1991.
8. 8. Carlsson, M. L. Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis). J. Neural Transm. 94:1-10, 1993.
9. 9. Carlsson, M.; Svensson, A. The noncompetitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA 494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. Life Sci. 47:1729-1736; 1990.
10. 10. Clineschmidt, B. V.; Martin, G. E.: Bunting, P. R.; Papp, N. L. Central sympathomimetic activity of ( + )-5-methyl-10,11 -dihydro-5-H-dibenzo[a,d]cycloheptan-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev. Res. 2:135-145; 1982.
11. 11. Colpaert, F. C.; Niemegeers, C. J. E.; Janssen, P. A. J. Discriminative stimulus properties of cocaine and d-amphetamine, and antagonism by haloperidol: A comparative study. Neuropharmacology 17:937-942; 1978.
12. 12. Colpaert, F. C.; Niemegeers, C. J. E.; Janssen, P. A. J. Discriminative stimulus properties of cocaine: Neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol. Biochem. Behav. 10:535-546; 1979.
13. 13. Danysz, W.; Essmann, U.; Bresink, I.; Wilke, R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48:111-118; 1994.
14. 14. Davies, J.; Francis, A. A.; Jones, A. W.; Watkins, J. C. 2-Amino-5-phosphonovalerate (2-APV), a potent and selective antagonist of amino acid-induced and synaptic excitation. Neurosci. Lett. 21:77-81; 1981.
15. 15. Davies, S. N.; Martin, D.; Millar, J. D.; Aram, J. A.; Church, J.; Lodge, D. Differences in results from in vivo and in vitro studies on the use-dependency of N-methyl-aspartate antagonism by MK-801 and other phencyclidine recptor ligands. Eur. J. Pharmacol. 145:141-152; 1988.
16. 16. Dingledine, R.; McBain, C. J.; MacNamara, J. O. Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11:334-338; 1990.
17. 17. Ditzler, K. Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneimittelforschung/Drug Res. 8:773-780; 1991.
18. 18. Fagg, G. E.; Olpe, H. R.; Pozza, M. F.; Baud, J.; Steinmann, M.; Schmutz, M.; Portet, C.; Baumann, P.; Thedinga, K.; Bittiger, H.; Allgeier, H.; Heckendorn, R.; Angst, C.; Brundish, D.; Dingwall, J. G. CGP 37849 and CGP 39551: Novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br. J. Pharmacol. 99:791-797; 1990.
19. 19. France, C. P.; Woods, J. H.; Ornstein, P. The competitive N-methyl-D-aspartate (NMDA) antagonist CGP 19755 attenuates the rate-decreasing effects of NMDA in rhesus monkeys without producing ketamine-like discriminative stimulus effects. Eur. J. Pharmacol. 159:133-139; 1989.
20. 20. Gold, L. H.; Balster, R. L. Effects of NMDA receptor antagonists in squirrel monkeys trained to discriminate the competitive NMDA recptor antagonist NPC 12626 from saline. Eur. J. Pharmacol. 230:285-292; 1993.
21. 21. Hiramatsu, M.; Cho, A. K.; Nabeshima, T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur. J. Pharmacol. 166:359-366; 1989.
22. 22. Johnson, K. M., Jr Neurochemistry and neurophysiology of phencyclidine. In: Meltzer, H. Y., ed. Psychopharmacology: The third generation of progress. New York: Raven Press; 1987:1581-1588.
23. 23. Kemp, J. A.; Foster, A. C.; Wong, E. H. F. Noncompetitive antagonists of excitatory amino acid receptors. Trends Neurol. Sci. 10: 294-298; 1987.
24. 24. Koe, B. K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199:649-661; 1976.
25. 25. Koek, W.; Woods, J. H.; Jacobson, A. E.; Rice, K. C. Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP. Psychopharmacology (Berlin) 93:437-442; 1987.
26. 26. Koek, W.; Woods, J. H.; Winger, G. D. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 245:969-974; 1988.
27. 27. Koek, W.; Colpaert, F. C; Woods, J. H.; Kamenka, J. M. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl)cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J. Pharmacol. Exp. Ther. 250:1019-1027; 1989.
28. 28. Koek, W.; Woods, J. H.; Colpaert, F. C. N-methyl-D-aspartate antagonism and phencyclidine-like activity: A drug discrimination analysis. J. Pharmacol. Exp. Ther. 253: 1017-1025; 1990.
29. 29. Lehman, J. The NMDA receptor. Drugs Future 14:1059-1071; 1989.
30. 30. Loscher, W.; Annies, R.; Honack, D. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J. Pharmacol. 242:263-274; 1993.
31. 31. Mansbach, R. S.; Balster, R. L. Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacol. Biochem. Behav. 39:971-975; 1991.
32. 32. McDermott, A. B.; Mayer, M. J.; Westbrook, G. L.; Smith, S. J.; Baker, J. L. NMDA-receptor activation increases cytoplasmatic calcium concentration in cultured spinal cord neurons. Nature 321:519-522; 1986.
33. 33. McElroy, J. F.; Feldman, R. S. Discriminative stimulus properties of fenfluramine: Evidence for serotonergic involvement. Psychopharmacology (Berlin) 83:172-178; 1984.
34. 34. Meldrum, B. Possible therapetic applications of antagonists of excitatory amino acid neurotransmitters. Clin. Sci. 68:113-122; 1985.
35. 35. Murphy, D. E.; Schneider, J.; Boehm, C.; Lehman, J.; Williams, M. Binding of [H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: A selective, high-affinity ligand for N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 240:778-784; 1987.
36. 36. Olney, J. W. Excitatory amino acids and neuropsychiatric disorders. Biol. Psychol. 26:505-525; 1989.
37. 37. Parsons, C. G.; Gruner, R.; Rozental, J.; Millar, J.; Lodge, D. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29:1111-1116; 1993.
38. 38. Raffa, R. B.; Ortegon, M. E.; Robisch, D. M.; Martin, G. E. In vivo demonstration of the enhancement of MK-801 by L-glutamate. Life Sci. 44:1593-1599; 1989.
39. 39. Rao, T. S.; Kim, H. S.; Lehman, J.; Martin, L. L.; Wood, P. L. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: Regional studies in the rat. J. Neurochem. 54:1157-1162; 1990.
40. 40. Sanger, D. J.; Terry, P.; Katz, J. L. Memantine has phencyclidine-like but not cocaine-like discriminative stimulus effect in rats. Behav. Pharmacol. 3:265-268; 1992.
41. 41. Schmidt, W. J.; Zadow, B.; Kretschmer, B. D.; Huber, W. Anticataleptic potencies of glutamate-antagonists. Amino Acids 1:225-237; 1991.
42. 42. Svensson, A.; Pileblad, E.; Carlsson, M. A comparison between the noncompetitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J. Neural Transm. 85:117-129; 1991.
43. 43. Tallarida, R. J.; Murray, R. B. Manual of pharmacological calculations with computer programs. 2nd ed. New York: Springer Verlag; 1986:153-164.
44. 44. Tricklebank, M. D.; Singh, L.; Oles, R. J.; Wong, E. H. F.; Iversen, S. D. A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine. Eur. J. Pharmacol. 141:497-501; 1987.
45. 45. Tricklebank, M. D.; Singh, L.; Oles, R. J.; Preston, C.; Iversen, S. D. The behavioural effects of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:127-135; 1989.
46. 46. Wenk, G. L.; Danysz, W.; Mobley, S. L. Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat. Brain Res. 655:7-11; 1994.
47. 47. White, F. J.; Appel, J. B. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology (Berlin) 73:110-115; 1981.
48. 48. Whitton, P. S.; Biggs, C. S.; Pearce, B. R.; Fowler, L. J. MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J. Neurochem. 58:1573-1575; 1992.
49. 49. Wiley, J. L.; Balster, R. L. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in squirrel monkeys trained to discriminate D-CPPene (SDZ EAA 494) from vehicle. Psychopharmacology (Berlin) 116:266-272; 1994.
50. 50. Willetts, J.; Balster, R. L. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline. J. Pharmacol. Exp. Ther. 251:627-633; 1989.
51. 51. Willets, J.; Bobelis, D. J.; Balster, R. L. Drug discrimination based on the competitive N-methyl-D-aspartate antagonist, NPC 12626. Psychopharmacology (Berlin) 99:458-462; 1989.
52. 52. Willetts, J.; Balster, R. L.; Leander, J. D. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol. Sci. 11:423-428, 1990.
53. 53. Willets, J.; Clissold, D. B.; Hartman, T. L.; Brandsgaard, R. R.; Hamilton, G. S.; Ferkany, J. W. Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonist. J. Pharmacol. Exp. Ther. 265:1055-1062; 1993.
54. 54. Wong, E. H. F.; Kemp, J. A.; Priestley, T.; Knight, A. R.; Woodruff, G. N.; Iversen, L. L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83:7104-7108; 1986.